Cargando…

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review

Hypertrophic cardiomyopathy (HCM) is an inherited primary myocardial disease characterized by asymmetrical/symmetrical left ventricle (LV) hypertrophy, with or without LV outflow tract (LVOT) dynamic obstruction, and poor prognosis. Cardiac resynchronization therapy (CRT) has emerged as a minimally...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radu, Andrei Dan, Cojocaru, Cosmin, Onciul, Sebastian, Scarlatescu, Alina, Zlibut, Alexandru, Nastasa, Alexandrina, Dorobantu, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952999/ https://www.ncbi.nlm.nih.gov/pubmed/36830887 http://dx.doi.org/10.3390/biomedicines11020350

Ejemplares similares

Cardiac Resynchronization Therapy and Left Atrial Remodeling: A Novel Insight?
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Exploring the Continuum of Hypertrophic Cardiomyopathy—From DNA to Clinical Expression
por: Popa-Fotea, Nicoleta Monica, et al.
Publicado: (2019)

Cardiac Magnetic Resonance Imaging in Appraising Myocardial Strain and Biomechanics: A Current Overview
por: Zlibut, Alexandru, et al.
Publicado: (2023)

Non-revascularized chronic total occlusions impact on substrate and post-ablation results in drug-refractory electrical storm
por: Cojocaru, Cosmin, et al.
Publicado: (2023)

Ratio between Right Ventricular Longitudinal Strain and Pulmonary Arterial Systolic Pressure: Novel Prognostic Parameter in Patients Undergoing Cardiac Resynchronization Therapy
por: Deaconu, Silvia, et al.
Publicado: (2021)

The prognostic value of right ventricular longitudinal strain and 3D ejection fraction in patients with dilated cardiomyopathy
por: Vîjîiac, Aura, et al.
Publicado: (2021)

The Role of Left-Atrial Mechanics Assessed by Two-Dimensional Speckle-Tracking Echocardiography to Differentiate Hypertrophic Cardiomyopathy from Hypertensive Left-Ventricular Hypertrophy
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2021)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight
por: Micheu, Miruna Mihaela, et al.
Publicado: (2018)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Forgotten No More—The Role of Right Ventricular Dysfunction in Heart Failure with Reduced Ejection Fraction: An Echocardiographic Perspective
por: Vijiiac, Aura, et al.
Publicado: (2021)

The mechanisms, diagnosis and management of mitral regurgitation in mitral valve prolapse and hypertrophic cardiomyopathy
por: Popa, Mihaela Octavia, et al.
Publicado: (2016)

The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2020)

Monomorphic VT Non-Inducibility after Electrical Storm Ablation Reduces Mortality and Recurrences
por: Vătășescu, Radu, et al.
Publicado: (2022)

Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy
por: Micheu, Miruna Mihaela, et al.
Publicado: (2020)

Case Report: Pulmonary Vein Isolation as a Tailored Treatment for Recurrent Ventricular Tachycardia During Hemodialysis in a Patient With Right Coronary Artery Chronic Total Occlusion
por: Cojocaru, Cosmin, et al.
Publicado: (2022)

Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy
por: Rosu, Radu Ovidiu, et al.
Publicado: (2022)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Cardiac resynchronization in pacing-associated cardiomyopathy: Is it time to upgrade?
por: Hutchinson, Mathew D.
Publicado: (2021)

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
por: Nagata, Yoshiki, et al.
Publicado: (2017)

Peripartum cardiomyopathy and cardiac resynchronization therapy: Case reports and literature review
por: Wang, Norman C., et al.
Publicado: (2021)

Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy
por: Obrzut, Sebastian, et al.
Publicado: (2010)

Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator
por: Bang, Ji Hyun, et al.
Publicado: (2015)

The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy
por: Kerley, Robert N., et al.
Publicado: (2023)

Response to Cardiac Resynchronization Therapy in Cardiomyopathy Patients with Right Bundle Branch Block
por: Zand, Sara, et al.
Publicado: (2023)

Cardiac resynchronization therapy in the Republic of Moldova: The beginning of the journey
por: Darciuc, Radu, et al.
Publicado: (2022)

Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire
por: Capota, Razvan, et al.
Publicado: (2020)

Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy
por: Verschure, Derk O., et al.
Publicado: (2015)

Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy
por: Tolosana, José Maria, et al.
Publicado: (2018)

Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy
por: Gi, Weng-Tein, et al.
Publicado: (2020)

Pheochromocytoma and Hypertrophic Cardiomyopathy Leading to Cardiac Arrest
por: Niu, Kevyn, et al.
Publicado: (2023)

Cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy: long-term follow up
por: de Araújo, Edgard Ferreira, et al.
Publicado: (2014)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review
por: Shehram, Muhammad, et al.
Publicado: (2023)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
por: Liu, Fuwei, et al.
Publicado: (2023)

A Novel and Simple Exercise Test Parameter to Assess Responsiveness to Cardiac Resynchronization Therapy
por: Cozlac, Alina-Ramona, et al.
Publicado: (2020)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
por: Achim, Alexandru, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
por: Ebrille, Elisa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_29qqoilo01di95rmlngt6548fr